Jobs / United States / Beam Therapeutics INC

Engineer II/Senior Engineer I, Automation and MES

Beam Therapeutics INC · 🇺🇸 Durham, NC

Sponsorship verdict

Sponsorship possible

One solid signal, not two — worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 7 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 1 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
  • Confirmed live todayWhen a source last listed this job as open.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.

Start free →

Or apply yourself on the official page →

Sponsor Radar — Beam Therapeutics INC

7 H-1B filings certified since Oct 2025

The US Department of Labor certified 7 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 1 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).

Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Beam Therapeutics INC →

About the role

Company Overview: Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases. Position Overview: Beam is looking for a highly energetic Engineer II/Senior Engineer I, Automation and MES with GMP manufacturing experience focused on design, installation, configuration, maintenance support, and validation of Rockwell PharmaSuite system. Additionally, the role will support other automation systems including DeltaV, PI, and Igniton. The candidate will be a core team member for the Engineering and Facilities team developing and maintaining automation systems at the new multi-modality site in Durham / RTP, NC. This is a fantastic opportunity to help continue to develop and grow Beam manufacturing and automation long -term strategy. The successful candidate will show initiative in helping with the development of Beam’s MES Master Recipes and overall automation strategy to support clinical and commercial manufacturing of the current cell and gene therapy manufacturing modality platforms. They will provide technical expertise and assistance in execution of Capital Improvement and Compliance projects. They will also possess the ability to successfully interface with multidisciplinary teams building strong cross functional relationships and engage and collaborate with external partners in IT, supply chain, process development, manufacturing operations, quality, validation, and finance. Responsibilities : • Serve as the site subject matter expert for Rockwell FactoryTalk PharmaSuite MES, including configuration, master recipe and workflow authoring, exception handling, and defect triage. • Lead the design, implementation, and lifecycle management of electronic batch records (EBR) for clinical and commercial cell therapy manufacturing processes, including phase design, calculations, transitions, CPP/process limits, and electronic signature flows. • Convert paper master batch records into compliant, operator-friendly electronic execution in partnership with Manufacturing, MS&T, and Quality. • Own MES change control end to end: impact assessment, requirement/functional/configuration specifications, test protocol authoring and execution (IQ/OQ/PQ), deviation documentation, and requirements traceability matrix support. • Support MES system implementation and lifecycle, including system architecture, platform components, and interfaces to partner systems (SAP, LIMS, CMMS, PI, and patient logistics chain-of-identity / chain-of-custody systems). • Support the deployment of PharmaSuite MES to new and existing suites, processes, and products as the site scales capacity across modalities. • Support inspection and licensure readiness, including mock pre-license inspection runs, audit trail review, data integrity controls per 21 CFR Part 11 and EU Annex 11, and MES business continuity procedures. • Provide floor-side support, hypercare, and operator training during go-live; translate operator feedback into practical recipe and workflow improvements. •

View the official posting →

Source: Greenhouse (employer board) First seen: 2026-10-16 Last confirmed: 2026-10-16 How our data works → Report this job

Similar opportunities